Researchers from Northeastern University and Massachusetts General Hospital are studying ways to predict which women with benign breast disease are at high risk of developing breast cancer.
Funded by a three-year, $1.3 million grant from the advocacy group Susan G. Komen for the Cure, Barry Karger of Northeastern and Dr. Dennis Sgroi of Mass. General hope to identify proteins that can be used to decide who would benefit from close monitoring or preventive measures.
About white coat notes
|White Coat Notes covers the latest from the health care industry, hospitals, doctors offices, labs, insurers, and the corridors of government. Chelsea Conaboy previously covered health care for The Philadelphia Inquirer. Write her at firstname.lastname@example.org. Follow her on Twitter: @cconaboy.|
Gideon Gil, Health and Science Editor
Elizabeth Comeau, Senior Health Producer